Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Messi1966 I emailed TS for the attention of Ian Robert’s CEO voicing all the concerns from the shareholders on this chat thread. I haven’t got a reply but know it was delivered, so I am not sure if my email prompted the recent announcement or not ? If it did great. I am sending another one today asking for a more detailed announcement on the independent testing and when exactly they are going to formally submit to the FDA.
Do not worry I will keep on at this because I have a lot of money riding on this investment.
Also going to email Aquis like the other member did for an explanation on why share price goes down on sells nearly immediately but not from buys. The market makers are at their work as you can see the recent buys and no movement.
TruSpine Technologies plc
("TruSpine" or the "Company")
Survey of Cervi-LOK™
TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its proprietary, pioneering "screwless," spinal (vertebral) stabilisation system, announces that its cornerstone Cervi-LOK™ device has completed Round II testing.
Round II testing consisted of a cadaver study which was conducted at the Upstate Medical School in Syracuse, New York, and was performed by two highly experienced surgeons who are also members of TruSpine's medical advisory board: Dr. Mark Smith / Neurosurgeon (tested on May 6) and Dr. William Lavelle / Orthopaedic spine surgeon (tested on May 7). Also in attendance was Nathan Erickson, the Lead Engineer from TruSpine's engineering partner, LincoTek, Inc., as well as Professor Frank Boehm, TruSpine's Chief Technical Consultant.
The objectives of the cadaver study included evaluating the usability of the instruments to implant the system, as well ease of insertion, grasp of the vertebrae and strength of the implant system. The surgeons conducted their study independent of one another, further enhancing the validity of the evaluation. The procedures were recorded on video, and pending editing, this should be available for general viewing on the TruSpine website in due course.
A stabilisation from the C2 to C5 vertebrae was achieved, on average in less than 15 minutes; in one instance, a unilateral stabilisation was achieved in 14 minutes from the time of the initial skin incision until the time of complete insertion of the implant, which is an exceptional outcome relative to current technologies as detailed below, even for a highly skilled surgeon.
No X-Rays were required, no injury to the bone was noted, and - as further confirmation of the benefits of the system, there was no possibility of injury to vascular or neurologic structures. This is in contrast to current technology, which can take 30 to 45 minutes or longer, requires significant intraoperative X-Rays, and can be complicated by injuries to critical blood vessels, nerves or even the spinal cord.
Dr. Smith was particularly impressed with the versatility and flexibility of the device and Dr. Lavelle thought that the system was excellent, noting some additional indications beyond those originally stated.
The overall view of both participating surgeons was that the system was extremely effective, efficient and has a great deal of appeal to practicing surgeons, with ease and convenience and avoidance of injury to critical structures. In addition, the Cervi-LOK™ system was highly praised for its flexibility and versatility and it was mutually agreed that the potential for commercial success was high.
Ian Roberts, CEO of TruSpine Technologies plc, commented: "We are delighted to receive this compelling feedback on the Cervi-LOK™ system by highly experienced surgeons. Both surgeons involve
Investegate |TruSpine Technolgs. Announcements | TruSpine Technolgs.: Further re Subscription
https://www.investegate.co.uk/truspine-technolgs.--tsp-/rns/further-re-subscription/202105250700066499Z/
It is understandable that everyone on this thread is getting anxious over the share price. I myself have a lot of money invested in Truspine from the IPO and buying more recently as the price dropped, now is not the time to panic we are all probably in it for the long haul. I still firmly believe that this company will do very well in the long term. We all need to be behind the company as much as possible for the sake of our investment.
I totally agree with all the comments regarding the Truspine management and the lack of communication with Shareholders & potential investors. It is not acceptable that up to date announcements have not been released to keep everyone in the loop.
Communication is the key, without it people are left in the dark & anxiety creeps in. I am going to try and contact the company myself & ask to speak to the CEO for an explanation as a shareholder.
If I am successful getting through I will share with you all what was said in my next post.
Keep the faith in TS .
Messi196 if your down £15k I probably have the equivalent holding or slightly more and totally agree with you. I sound like a broken record but looking at the BOD of directors they seem to have little involvement. This is down to Ian Roberts the so called CEO. This man continues to fail at putting out news/ informing shareholders what the hell is going on and the share price begins to fall now at bid of 6.9p !!!!!! Alice777 the share price is not stagnating it is free falling and what is Robert’s & Co doing absolutely nothing apart from fixing his website after 9 months. This man needs to go and a replacement found immediately he is doing nothing to help the share price or give shareholders any confidence what so ever by keeping them informed on anything. My prediction is that the share price will go to 4-5p at this rate.
I think until further news comes out regarding the testing results and manufacturing the price will stay stagnant but I’m convinced this will be a good share for us all, they’ve finally got the website price in line with the share price so could be a start of further things to come.
Sorry guys I meant to say more purchases than sales
I’ve just had the same info back Daytrade250, that Dazzler25 received, not sure what to make of it other than a sea of red clearly is not what it seems and there or possibly more sales than we are aware. I agree with Dazzler25 this is a great company and moving forward I see a great windfall from the shares I and others have purchased and at this price they are certainly worth a punt, I think we just need to here some good news on how the testing has gone and when to expect FDA clearance and hopefully that will give us as shareholders more confidence moving forward
Just contacted this website LSE to complain why they are putting up sells when they are buys . It must be noted that LSE has nothing to do with the Aquis exchange they are just an information and trading site. This is the reply I got ;
Hi R******,
We calculate the trade type based on the trade price being higher or lower than the mid price at the time of the transaction. Sometimes this calculation does not work, or the price is the opposite side of the mid price. This means we are either unable to calculate what type of trade this is at all, or the calculation shows it as the wrong type of trade (a buy instead of a sell for example).
Our method of calculating the type of trade is the industry standard, and while we are not provided by the type of trade from the stock market we will continue to use it.
If the London Stock Exchange informed everyone if a buy was a buy and a sell was a sell, we wouldn't have to make any calculations at all but unfortunately, they don't.
We do have a disclaimer at the very bottom of the website for this reason, as due to the fact the Stock Exchange don't tell any website if a buy is a buy or a sell is a sell, we're forced to work it out ourselves. As mentioned, an algorithm is in place for this and is industry standard.
Kind regards
Craig
This proves that it is not all at it seems and certain sells are buys so when you see a sea of red it is more than likely many buys are in there as well.
I still maintain the market makers are playing games with this stock for their own gain and sincerely hope that Aquis looks into it.
As an investment I do firmly believe that this is a really good company and will hopefully deliver big returns once FDA approval is gained otherwise I wouldn’t have put my hard earned cash into it.
The present price represents a bargain. It is an 80% saving on the IPO price.
Well I can’t see any other reason for what is happening, all I can say is the buying of those shares clearly shows a sell and not a purchase, unless you can shed any light on why it is shown like that !!!! I will make a point of contacting them tomorrow and will come back with my findings on this to share Daytrade250
Thanks for sharing your post with us Alice777. This is a shocking development. I have no doubt that you are telling us the true facts. It needs to be investigated immediately as this sheds a very poor light on the Aquis exchange.
I have invested a sizeable amount of money in Truspine to now find out that the share price is being manipulated by the MM which sickens me to the pit of my stomach. It just did not make sense why the price of the share was falling but it now it all makes sense.
Again what is the CEO Ian Robert’s doing about this??? The share price is now down nearly 80% from the IPO price of 0.35p. Robert’s has made no announcements and clearly isn’t being very proactive in protecting his shareholders interests.
In light of this information Alice777 It would be prudent to report your findings to the FCA plus contact Aquis tel- 020 3597 6321 to put in a complaint with all your evidence on the buy you made of 13125 shares that was listed as a sell on the Aquis trades, these Market Makers need to be stopped as quickly as possible.
I have been reading the recent posts and to be honest I am shocked and angered what is happening with the share price. I am an early investor of Truspine and invested simply because of the amazing potential the products they are developing have.
I totally agree with Dazzler25 that the MMakers are crippling the share price for their own gain.
To put it in perspective on Wednesday 18th May at 9.21am I instructed my broker to buy a further £9900 worth of shares which he did at a mid price of 7.55p for a total 131125 shares, later that day when I checked the share price & trades it showed my deal as a sell in Red and not a buy in blue ???? along with a drop in the share price. I then followed it up and there were further sells to then blue buys to match roughly the amount of shares I had bought at a much lower price to what I bought them at!!!-Simply put, the Market Makers are driving the price down at all our expense so that THEY can make money. They are doing the deals and are obviously putting some buys as sells which distorts the market. Im guessing this practice is legal but it should not be. It puts off potential investors that when they look at trades and see a sea of red and then decide against investing when the majority of time the reds are buys and not sells ??. This practice also spooks current investors that when they see so many sells decide to sell on the back of it.
The share price should never be sitting at this price and again I agree with Dazzy25 in the fact that nothing has changed from IPO apart from the delay in gaining FDA approval for the their first product due to Covid restrictions. I have no doubt this will come and the very reason I invested more money in the stock.
At the price the Market Makers have put this stock on the flip side represents a fantastic opportunity to potentially make a huge profit . I am in it for the long haul because I have faith it will come good.
I am new contributor to the chat because I had to make comment because what I see going on is not right.
Payinattn it shows a sea of red but this is completely false as the majority of reds are actually buys which I can prove. The market makers are playing havoc with this stock and should be ashamed of themselves. I know this because I have made a few purchases of truspine stock and when I go on to this exchange my purchases are shown as sells in red when I have bought them from my broker. This is down to the skip rats/market makers manipulating the stock price for their own gain. This stock should never be this price as nothing drastic has happened since IPO and they still seem to be on course for FDA approval. I hope the company make a few new announcements to give some clarity to us as investors. I have full faith in this investment and at this current price will probably buy some more.
It is amazing that we still have not heard anything from Robert’s let alone some news on their website/press on what is currently happening with the company.
The last statement indicated that they had the final part of the testing with third party surgeons prior to formally seeking FDA approval. It would be nice as an investor to be kept in the loop if this has happened & when FDA approval is likely to be granted!!! good old Ian Robert’s strikes again.
The man is obviously in his first CEO position and is clearly out off his depth. He should seek some form of help before he loses the share holders confidence completely.
I do believe if they get the FDA approval they will manufacture the product and get it used by surgeons first. I could not see a big company come in for a take over if it hasn’t been proven and tested in patients, definitely if this happens it will be one that the big American medical devise companies will be fighting over .
Mr Robert’s if you bother reading this can you please do something to give investors some news on what is going on and do something to get the share price moving back to the IPO level.
Hi Daytrade,
You make fair points! Danger of this being a lifestyle company but too soon to tell as the delays genuinely could be all out of the company’s control - it would take a simple interview to clarify the situation as you say - my initial faith in this was because of Schild’s involvement but we’ll see. Luckily I only bought a small amount sub 9p so I’m not overly concerned enough myself to draw the company into any activity. Good luck to all TSP because we’re gonna need it!
Glengarth I would slightly disagree on the point that TSP has great people in it possibly you are referring to investors rather management. I look at the IPO launch and the so called CEO Ian Robert’s giving a big speech on what was happening and how they are going to take on the world- Where is Ian “the ghost “Robert’s now??? He seems to be doing absolutely nothing along with the joke of a PR company they employ to deliver results or even keep investors informed. This is starting to become a serious issue in that they need to act in some form to keep investors informed.
The fact that Robert’s hasn’t even come out recently with some form of company statement is very worrying!!!
The last announcement was that they have to do a final lab test with third party surgeons before they submit to the FDA - Has this happened and what next please tells us Mr “Ghost “Robert’s????? Has this happened and is it the case that the results were not positive hence the further delay????
Once submitted it will take a further 90 days before they get approval to start actually selling this product.
The investors in TSP are basically in my opinion being treated like Mushrooms by Mr Robert’s the so called CEO kept in the dark and fed Sh#t.
In such a small company you would have thought this man would have been all over this and working to make things happen it looks from the outside he is probably furloughed on the golf course not giving a dam about what is happening.
There needs to be a vote of no confidence in this man and have him removed.
From memory having looked through the company's prospectus I think TSP is below the price of even it's pre-IPO fundraises - I suspect there are quite a few people feeling very peeved with the performance, even if it is attributable to Pandemic related delays to some degree...glad you are positive though - you are right that FDA approval will be a big step for TSP, especially given its failures in the past to achieve approval for its products.
I would like to know what makes you so certain TSP will win anything from Evrensel for not paying up for its subscription shares given the company's history of failure in pretty much everything? I hope the company does succeed in this area of course...otherwise it may seem to become a case of a company management unable to organise a pi55 up in a brewery!
TSP has some great people in it, just a shame it's not been the trajectory widely hoped for. Anyway, here's to the next 6-9 months for some solid news.
I total understand your frustration if you are an investor with Primorus Investments PLC and it has taken so long to get to this stage. I am struggling to see why the company said it was getting FDA approval back in 2017 and it still has not got it, was it a case of not enough funds?? They may pull there finger it out and make sure this product is launched this year . The CEO in my opinion is not doing a very good job in investor relations and would agree with Messi post that the PR company is absolutely useless. The share price should never have slid the way it has. It is time for these people to start making things happen.
Payinattn I totally respect your opinion. I am finding it difficult to get my head around, on the surface nothing has changed for this company since float apart from a delay in FDA approval due to the pandemic. The company has had recent positive lab tests with a view to submit to the FDA & launching the first product this year. The only negative was not getting the promised £250k from Evrensal capital partners but on the flip side they have since raised more money from other investors all be it at a lower price. The positive point is that they appear to have enough capital to finish the FDA and launch this year which is a massive boost for this small company. It also looks like they will succeed in legal action against Evrensal for breach of contract.
All in all the share price is massively undervalued given that it is all going in the same direction from the ipo at .33p . I personally was delighted to invest at the current price given that there is no reason for it to be trading at this apart from sells that have driven the price down.
Please Payinattn give me your thoughts am I missing something here?? Also have you invested in this stock or simply sidelining.
That was to you Payattn
I don’t know how you can say that the MM is NOT a company called Oberon Investment that increased its holding to over 4% which made them listed as major share holders. I have invested in this company because if the FDA approval comes through it has the potential to be a serious proposition. I really look forward to hearing your take on it.
Heard good news from my broker that some investment company bought more stock to take them over the 4% mark must be news coming ??
wow double digit number of trades, must be about half of trades this side of December
lol I believe AJ Bell has brought Aquis trading online today which might help with liquidity and exposure to the wider market...certainly as a medical tech company I wonder if this will benefit TSP?
>>>Glengarth LOL